Ola Winqvist
Overview
Explore the profile of Ola Winqvist including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
2306
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Stranneheim H, Lagerstedt-Robinson K, Magnusson M, Kvarnung M, Nilsson D, Lesko N, et al.
Genome Med
. 2021 Mar;
13(1):40.
PMID: 33726816
Background: We report the findings from 4437 individuals (3219 patients and 1218 relatives) who have been analyzed by whole genome sequencing (WGS) at the Genomic Medicine Center Karolinska-Rare Diseases (GMCK-RD)...
12.
Vollmer T, Schlickeiser S, Amini L, Schulenberg S, Wendering D, Banday V, et al.
Sci Transl Med
. 2021 Jan;
13(576).
PMID: 33441425
Chemotherapy has direct toxic effects on cancer cells; however, long-term cancer control and complete remission are likely to involve CD8 T cell immune responses. To study the role of CD8...
13.
Xia C, Olsen T, Zirakzadeh A, Almamoun R, Sjoholm L, Dahlstrom J, et al.
Front Oncol
. 2020 Dec;
10:598872.
PMID: 33363029
We studied DNA methylation profiles in four different cell populations from a unique constellation of monozygotic triplets in whom two had developed Hodgkin Lymphoma (HL). We detected shared differences in...
14.
Kagedal A, Hjalmarsson E, Farrajota Neves da Silva P, Piersiala K, Kumlien Georen S, Margolin G, et al.
Sci Rep
. 2020 Dec;
10(1):22352.
PMID: 33339891
Recurrence in oral squamous cell carcinoma (OSCC) significantly reduces overall survival. Improved understanding of the host's immune status in head and neck cancer may facilitate identification of patients at higher...
15.
Zhang L, Zirakzadeh A, Rosvall J, Hedlund M, Hu P, Riklund K, et al.
Investig Clin Urol
. 2020 Dec;
62(1):39-46.
PMID: 33314806
Purpose: Nearly half of penile cancers are related to human papillomavirus (HPV) infection. Investigations of tumor- and HPV-specific T cell reactivity in regional lymph nodes (LNs) from patients with penile...
16.
Krantz D, Mints M, Winerdal M, Riklund K, Rutishauser D, Zubarev R, et al.
Scand J Immunol
. 2020 Aug;
92(6):e12926.
PMID: 32862475
In the effort of developing new immunotherapies, the sentinel node (SN) has proven a promising source from which to harness an effective antitumour T cell response. However, tumour immune escape,...
17.
Hiltbrunner S, Mints M, Eldh M, Rosenblatt R, Holmstrom B, Alamdari F, et al.
Sci Rep
. 2020 Apr;
10(1):5960.
PMID: 32249794
Invasive urinary bladder cancer shows high recurrence rates after cystectomy even with apparent complete downstaging at cystectomy. Exosomes are nano-sized vesicles important in cell-cell communication, which have been hypothesized to...
18.
Rosenblatt R, Lorentzi G, Bahar M, Asad D, Forsman R, Johansson M, et al.
Scand J Urol
. 2020 Jan;
54(1):46-51.
PMID: 31960752
To evaluate the extent and plausible effects of blood transfusions given during cisplatin-based neoadjuvant chemotherapy (NAC) on overall survival in patients with muscle-invasive urothelial bladder cancer (MIBC) undergoing NAC and...
19.
Zirakzadeh A, Sherif A, Rosenblatt R, Bergman E, Winerdal M, Yang D, et al.
Scand J Immunol
. 2019 Dec;
91(2):e12830.
PMID: 31823416
Tumour infiltrating B cells and CD38 plasma cells have been correlated with survival in different malignancies but their role in urinary bladder cancer is unclear. IL-10 is a multifunctional cytokine...
20.
Alvaeus J, Rosenblatt R, Johansson M, Alamdari F, Jakubczyk T, Holmstrom B, et al.
World J Urol
. 2019 Nov;
38(9):2207-2213.
PMID: 31760442
Purpose: To examine the relationship between the number of tumour draining sentinel nodes (SNs) and pathoanatomical outcomes, in muscle-invasive bladder cancer (MIBC), in patients undergoing neoadjuvant chemotherapy (NAC) and radical...